EP1758864 - Substituted tetrahydro-2H-isoquinolin-1-one derivatives, method for their preparation, and their use as medicaments [Right-click to bookmark this link] | |||
Former [2007/10] | SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICAMENTS | ||
[2012/27] | Status | No opposition filed within time limit Status updated on 14.02.2014 Database last updated on 17.07.2024 | Most recent event Tooltip | 17.07.2015 | Lapse of the patent in a contracting state New state(s): HU, LU | published on 19.08.2015 [2015/34] | Applicant(s) | For all designated states Sanofi-Aventis Deutschland GmbH Brüningstrasse 50 65929 Frankfurt am Main / DE | [2013/15] |
Former [2007/10] | For all designated states Sanofi-Aventis Deutschland GmbH Brüningstrasse 50 65929 Frankfurt am Main / DE | Inventor(s) | 01 /
PEUKERT, Stefan 19 Albermarle Street Arlington, MA 02476 / US | 02 /
GUESSREGEN, Stefan An der Laach 12 65205 Wiesbaden / DE | 03 /
HOFMEISTER, Armin Am Doktorweg 6 55278 Dexheim / DE | 04 /
SCHREUDER, Herman Jahnstrasse 22 65719 Hofheim-Lorsbach / DE | 05 /
SCHWAHN, Uwe Antoniterweg 8 65843 Sulzbach / DE | [2007/10] | Application number, filing date | 05754335.7 | 01.06.2005 | [2007/10] | WO2005EP05871 | Priority number, date | DE20041028973 | 16.06.2004 Original published format: DE102004028973 | [2007/10] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO2005123687 | Date: | 29.12.2005 | Language: | DE | [2005/52] | Type: | A1 Application with search report | No.: | EP1758864 | Date: | 07.03.2007 | Language: | DE | The application published by WIPO in one of the EPO official languages on 29.12.2005 takes the place of the publication of the European patent application. | [2007/10] | Type: | B1 Patent specification | No.: | EP1758864 | Date: | 10.04.2013 | Language: | DE | [2013/15] | Search report(s) | International search report - published on: | EP | 29.12.2005 | Classification | IPC: | C07D217/24, C07D417/14, C07D401/12, C07D405/04, C07D409/04, C07D401/04, C07D401/14, C07D413/14, C07D405/14, A61K31/472, A61K31/4725, A61P9/00 | [2007/10] | CPC: |
C07D413/14 (EP,US);
C07D217/24 (EP,KR,US);
A61K31/472 (KR);
A61P17/00 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
C07D401/04 (EP,US);
C07D401/12 (EP,US);
C07D401/14 (EP,US);
C07D405/04 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/10] | Title | German: | Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente | [2012/27] | English: | Substituted tetrahydro-2H-isoquinolin-1-one derivatives, method for their preparation, and their use as medicaments | [2012/27] | French: | Dérivés substitués de tetrahydro-2H-isoquinolein-1-one, leur procédé de préparation et leur utilisation en tant que médicaments | [2012/27] |
Former [2007/10] | SUBSTITUIERTE TETRAHYDRO-2H-ISOCHINOLIN-1-ON-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT | ||
Former [2007/10] | SUBSTITUTED TETRAHYDRO-2H-ISOQUINOLIN-1-ONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF THE SAME AS MEDICAMENTS | ||
Former [2007/10] | DERIVES SUBSTITUES DE TETRAHYDRO-2H-ISOQUINOLEIN-1-ONE, LEUR PROCEDE DE PRODUCTION, ET LEUR UTILISATION EN TANT QUE MEDICAMENTS | Entry into regional phase | 16.01.2007 | National basic fee paid | 16.01.2007 | Designation fee(s) paid | 16.01.2007 | Examination fee paid | Examination procedure | 16.01.2007 | Examination requested [2007/10] | 30.10.2009 | Despatch of a communication from the examining division (Time limit: M04) | 18.02.2010 | Reply to a communication from the examining division | 06.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 11.01.2012 | Reply to a communication from the examining division | 18.06.2012 | Communication of intention to grant the patent | 06.09.2012 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 19.10.2012 | Communication of intention to grant the patent | 27.02.2013 | Fee for grant paid | 27.02.2013 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.10.2009 | Opposition(s) | 13.01.2014 | No opposition filed within time limit [2014/12] | Fees paid | Renewal fee | 02.07.2007 | Renewal fee patent year 03 | 30.06.2008 | Renewal fee patent year 04 | 30.06.2009 | Renewal fee patent year 05 | 30.06.2010 | Renewal fee patent year 06 | 13.06.2011 | Renewal fee patent year 07 | 24.05.2012 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 01.06.2005 | CY | 10.04.2013 | CZ | 10.04.2013 | DK | 10.04.2013 | EE | 10.04.2013 | FI | 10.04.2013 | IT | 10.04.2013 | LT | 10.04.2013 | MC | 10.04.2013 | NL | 10.04.2013 | PL | 10.04.2013 | RO | 10.04.2013 | SE | 10.04.2013 | SI | 10.04.2013 | SK | 10.04.2013 | TR | 10.04.2013 | AT | 01.06.2013 | IE | 01.06.2013 | LU | 01.06.2013 | BE | 30.06.2013 | CH | 30.06.2013 | LI | 30.06.2013 | FR | 01.07.2013 | BG | 10.07.2013 | GB | 10.07.2013 | GR | 11.07.2013 | ES | 21.07.2013 | IS | 10.08.2013 | PT | 12.08.2013 | DE | 01.01.2014 | [2015/34] |
Former [2015/32] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
TR | 10.04.2013 | ||
AT | 01.06.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
FR | 01.07.2013 | ||
BG | 10.07.2013 | ||
GB | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
DE | 01.01.2014 | ||
Former [2014/51] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
AT | 01.06.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
FR | 01.07.2013 | ||
BG | 10.07.2013 | ||
GB | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
DE | 01.01.2014 | ||
Former [2014/24] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
FR | 01.07.2013 | ||
BG | 10.07.2013 | ||
GB | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
DE | 01.01.2014 | ||
Former [2014/22] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
BG | 10.07.2013 | ||
GB | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
DE | 01.01.2014 | ||
Former [2014/21] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
BG | 10.07.2013 | ||
GB | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/20] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
IE | 01.06.2013 | ||
BE | 30.06.2013 | ||
CH | 30.06.2013 | ||
LI | 30.06.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/18] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
BE | 30.06.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/11] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
IT | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
RO | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/10] | CY | 10.04.2013 | |
CZ | 10.04.2013 | ||
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
SK | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/09] | CY | 10.04.2013 | |
DK | 10.04.2013 | ||
EE | 10.04.2013 | ||
FI | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2014/08] | CY | 10.04.2013 | |
FI | 10.04.2013 | ||
LT | 10.04.2013 | ||
MC | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2013/52] | CY | 10.04.2013 | |
FI | 10.04.2013 | ||
LT | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2013/50] | FI | 10.04.2013 | |
LT | 10.04.2013 | ||
NL | 10.04.2013 | ||
PL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
BG | 10.07.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2013/49] | FI | 10.04.2013 | |
LT | 10.04.2013 | ||
NL | 10.04.2013 | ||
SE | 10.04.2013 | ||
SI | 10.04.2013 | ||
GR | 11.07.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2013/48] | LT | 10.04.2013 | |
NL | 10.04.2013 | ||
SI | 10.04.2013 | ||
ES | 21.07.2013 | ||
IS | 10.08.2013 | ||
PT | 12.08.2013 | ||
Former [2013/47] | LT | 10.04.2013 | |
SI | 10.04.2013 | ||
PT | 12.08.2013 | ||
Former [2013/37] | SI | 10.04.2013 | Cited in | International search | [A]US3594380 (SULKOWSKI THEODORE S) [A] 1,8 * abstract *; | [AD]EP0355750 (WARNER LAMBERT CO [US]) [AD] 1,8,13 * claims 1,20 *; | [AD]WO9911624 (GUILFORD PHARM INC [US]) [AD] 1-17 * page 22, line 15 - page 24, line 24; example 1; claim -; table VIII *; | [AD]WO02090334 (KUDOS PHARM LTD [GB], et al) [AD] 1-17 * page 6, line 10 - line 15 * * page 20, line 25 - page 23, line 5 * * claim - *; | [AD] - J. H. RIGBY ET AL, "Nucleophilic Addition of Silyl Enol Ethers to Aromatic Nitro Compounds: A Facile Synthesis of alpha-Nitroaryl Carbonyl Compounds", JOURNAL OF ORGANIC CHEMISTRY, (1984), vol. 49, no. 23, pages 4569 - 4571, XP002349380 [AD] 1 * Seite 4570, Tabelle I, "entry 6", "pyridone" * DOI: http://dx.doi.org/10.1021/jo00197a061 | [A] - J. H. RIGBY ET AL, "Preparation of Highly Substituted 2-Pyridones by Reaction of Vinyl Isocyanates and Enamines", JOURNAL OF ORGANIC CHEMISTRY, (1989), vol. 54, no. 1, pages 224 - 228, XP002349381 [A] 1 * Seite 226, linke Spalte, Verbindung 9; Seite 227, rechte Spalte, Zeilen 26-38 * DOI: http://dx.doi.org/10.1021/jo00262a047 | Examination | WO2005097750 |